In healthcare partnerships, compensation is often treated as a contract term. It is negotiated, signed, and filed away.

But in day-to-day operations, compensation functions like an operating signal. It tells the clinical team what the organization actually values, regardless of what the mission statement says.

This is a structural stress point in MSO partnerships: the shift from profit-based to production-based incentives. When a physician transitions from an owner model where income is tied to the practice's net profit to a platform model where income is tied more directly to collections, wRVUs, or productivity, the fundamental incentives change.

Incentives act like gravity. If you change the math of how physicians earn a living, you predictably change how they manage time, schedules, staffing needs, and patient flow.

In a compliant MSO model, compensation structures should avoid being tied to referrals and be created carefully when tied to productivity or volume. The issue is not productivity itself, but whether incentives are structured in a way that creates improper pressure, compliance risk, or quality drift.

The Predictable Response to Production Models

In many MSO transactions, physician compensation shifts from bottom-line economics to top-line economics. In an owner model, the physician keeps what is left, which encourages efficiency, cost control, and managing overhead. In a platform model, the physician eats what they kill, which encourages volume, intensity, and output.

That shift creates immediate time compression. If income is now tightly tied to volume, the rational response for any high-performing physician is to increase output. Without structural checks, that pressure eventually alters clinical behavior. Visit times get shorter as physicians try to fit the same clinical work into ten minutes instead of fifteen. Documentation becomes more sensitive as the focus shifts to coding complexity to maximize wRVUs, which can trigger compliance audits if not managed correctly. Supervision stretches as physicians are tempted to oversee more mid-level providers than is operationally sustainable in order to capture incident-to revenue.

This is often driven by a system that rewards volume more than it rewards stability.

The Growth Assumption Gap

A common friction point in year one is the gap between the financial model and clinical reality.

Many compensation models are built on a growth assumption, the idea that with MSO marketing and operational support, the physician's volume will immediately grow by ten to twenty percent to offset any reduction in base draw or overhead allocation. The logic sounds simple: you will make the same money, you just have to see two more patients a day.

In practice, this rarely happens in month one. Operational friction from learning a new EMR, waiting on payer credentialing for new locations, or training new support staff often causes individual productivity to dip in the first six months before it grows. This is the integration J-curve.

If the compensation model does not account for that transition dip, the physician takes a pay cut at the exact moment their integration workload is highest, which creates predictable tension.

A durable model uses a transition bridge, an income floor or a guaranteed ramp period, so the platform's own integration friction does not land directly on the physician's paycheck.

Designing Guardrails, Not Just Targets

To prevent a volume treadmill, compensation models need operational guardrails: standards that sit outside the productivity formula. A durable partnership defines these explicitly to protect the physician from their own incentive structure.

The first guardrail is schedule template integrity. Appointment length should be driven by clinical need, not income targets. Without a floor, the default answer to revenue pressure is to double-book the ten o'clock slot. The guardrail is minimum durations for defined visit types such as new patient, post-op, and complex consult that cannot be compressed below a safety threshold simply to add volume.

The second is supervision ratios. When models rely on NPs or PAs, there is a natural incentive to maximize physician-to-provider ratios. If a physician is signing off on charts they have not reviewed just to clear a queue, that is a licensure risk, not a productivity win. The guardrail is supervision ratios set by safety and specialty norms rather than just legal minimums, so supervision remains real and not theoretical.

The third is staffing ratios. If output increases, the support system needs to scale with it. A high-volume provider paired with a low-volume support team is a recipe for burnout, not EBITDA. The guardrail is staffing levels tied to volume tiers so that increased demand automatically triggers additional support rather than silent overload.

The fourth is quality and compliance cadence. High-production environments can increase documentation risk if there is not a consistent process. The guardrail is a predictable, non-punitive audit cadence that protects both physicians and the platform by catching coding issues early and keeping standards consistent.

What Should Be Clear Before Signing

Ambiguity in compensation creates anxiety. Before signing, physicians should understand and see in writing how the model behaves under stress.

The first thing to clarify is adjustment logic. If reimbursement rates drop, does physician compensation drop immediately or is there a buffer? If the MSO negotiates better payer rates, does the physician share in that upside?

The second is non-clinical duties. Chart review, mentorship, training, committee work, and leadership responsibilities take time away from production. These should be acknowledged and ideally stipended so they do not become unpaid obligations.

The third is a safety brake. There should be a documented mechanism to slow volume increases if quality indicators or patient experience scores begin to trend the wrong way.

Incentives Beat Slogans

You can talk about patient-centered culture every day, but if the compensation grid only rewards speed, you will get speed.

The goal of a well-structured MSO partnership is simple: doing the right thing for the patient should not financially punish the physician.

When guardrails are explicit, physicians can focus on care and productivity without worrying that the structure is quietly pushing them toward compromise.

How Verdira Approaches This

Clinical decisions remain with physicians. MSO scope is clearly defined in writing and tied to real services. Governance is clarified before signing so expectations remain stable after close. We build long-duration platforms and do not operate on forced exits.

If you are evaluating an MSO partnership or successor role and want to sanity-check structure and expectations, we are open to thoughtful conversations.

This article is for general educational purposes and is not legal advice.

Verdira is a healthcare acquisition platform focused on ophthalmology practices. Physician ownership. Transparent structure. No volume quotas. If you're looking for a different model, or you know a colleague who is, contact us today.

Contact info@verdira.com 307-381-3734 verdira.com